HUNTSVILLE, April 02, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology…
New portfolio structure reinforces ACM’s customer‑centric approach across core process technologies FREMONT, Calif., April 02, 2026 (GLOBE NEWSWIRE) — ACM…
Important Information Regarding Section 20(a) Individual Liability Claims Against Hercules Capital Officers NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) —…
This 2026 overview presents publicly available information regarding PawPrint Protocol’s nanoliposomal NAD+ and NMN formula for dogs, including CoQ10 and…